Paper - WANFANG MED ONLINE

You Position: Home > Paper

Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis

( views:17, downloads:4 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 14

DOI:: 10.1097/CM9.0000000000000309

Key Word:: Olfactomedin-like 3;Olfactomedin;Extracellular matrix;Transforming growth factor β1;Anoikis-resistance;microRNA-155

Abstract： Objective:Modern medical research has proven that human diseases are directly or indirectly related to genes.At the same time,genetic research has also brought updates to diagnostic techniques.Olfactomedin-like 3 (OLFML3) gene is a novel and clinically valuable gene.In order to better understand the role of OLFML3 in human diseases,we discuss and analyze the characteristics,function,and regulation mechanism of the OLFML3 gene in this review.Data sources:A comprehensive search in PubMed and ScienceDirect database for English up to March 2019,with the keywords of "Olfactomedin-like 3," "Olfactomedin," "extracellular matrix," "Transforming Growth Factor β1," "anoikis-resistance," and "microRNA-155." Study selection:Careful review of all relevant literature,the references of the retrieved articles were also screened to search for potentially relevant papers.Results:OLFML3 is a secreted glycoprotein with 406 amino acid residues,belonging to the Olfactomedin (OLF) family.Due to the particularity of its structure and differential expression,OLFML3 has unique biological functions that could be distinct from other members in the OLF family.The currently known functions include embryonic development function and tumorigenesis.The regulation mechanism is still under investigation.It is directly related to many human diseases.Conclusions:OLFML3 is a mukifunctional glycoprotein that is closely involved in embryonic development,tumor invasion,and metastasis.Unfortunately,current research on this important molecule is still very limited.Further investigations on the possible mechanism of OLFML3 biological functions and modulation will help us develop better diagnostics and treatments.

Reference

[1]Sandra, Schmitz,Gabriela, Bindea,Roxana Irina, Albu,etc.Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer.[J].2015,6(33).
[2]Jerhammar,F.,Roberg,K.,Johansson,A.-C.,etc.Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells[J].2012,10(9).
[3]Dunn, Louise L.,de Valence, Sarra,Tille, Jean-Christophe,etc.Biodegradable and plasma-treated electrospun scaffolds coated with recombinant Olfactomedin-like 3 for accelerating wound healing and tissue regeneration[J].2016,24(6).
[4]Kousuke Sasaki,Tamotsu Sugai,Kazuyuki Ishida,etc.Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma[J].2018,79.
[5]Daniel S. Greenspan,Marsha A. Moses,Gaoxiang Ge,etc.Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor[J].2007,104(24).
[6]Rongfang,Qiu,Hang,Shi,Shuang,Wang,etc.BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.[J].2018,8(10).
[7]Myung Kuk Joe,Seongsoo Sohn,Wonhee Hur,etc.Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells[J].2003,312(3).
[8]Sun, Shengjie,Zhang, Guoqing,Sun, Qiong,etc.Insulin-induced gene 2 expression correlates with colorectal cancer metastasis and disease outcome[J].2016,68(1).
[9]Butovsky, Oleg,Jedrychowski, Mark P.,Cialic, Ron,etc.Targeting miR-155 Restores Abnormal Microglia and Attenuates Disease in SOD1 Mice[J].2015,77(1).
[10]Polyak K,Weinberg RA.Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.[J].2009,9(4).
[11]Sasai Y,Inomata H,Haraguchi T.Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation[J].2008,134(5).
[12]Seok HY,Tatsuguchi M,Callis TE,etc.miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation.[J].2011,286(41).
[13]Arijit, Mukhopadhyay,Sangita, Talukdar,Ashima, Bhattacharjee,etc.Bioinformatic approaches for identification and characterization of olfactomedin related genes with a potential role in pathogenesis of ocular disorders.[J].2004,10.
[14]Robert R H, Anholt.Olfactomedin proteins: central players in development and disease.[J].2014,2.
[15]Hanahan,D.,Coussens,L..Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment[J].2012,21(3).
[16]Carys A,Pugh,Lindsay L,Farrell,Ailsa J,Carlisle,etc.Arginine to Glutamine Variant in Olfactomedin Like 3 (OLFML3) Is a Candidate for Severe Goniodysgenesis and Glaucoma in the Border Collie Dog Breed.[J].2019,9(3).
[17]Aguiar, RCT,Kim, SW,Rai, D,etc.Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis[J].2010,107(7).
[18]Isaac M. Chiu,Emiko T.A. Morimoto,Hani Goodarzi,etc.A Neurodegeneration-Specific Gene-Expression Signature of Acutely Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model[J].2013,4(2).
[19]Tomarev SI,Nakaya N.Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.[J].2009,40(2).
[20]De-Wever O,Demetter P,Mareel M,etc.Stromal myofibroblasts are drivers of invasive cancer growth.[J].2008,123(10).
[21]Peter Carmeliet,Rakesh K. Jain.Molecular mechanisms and clinical applications of angiogenesis[J].2011,473(TN.7347).
[22]Hassiba, Alaa J.,El Zowalaty, Mohamed E.,Nasrallah, Gheyath K.,etc.Review of recent research on biomedical applications of electrospun polymer nanofibers for improved wound healing[J].2016,11(6).
[23].Transcriptional profiling of subcutaneous adipose tissue in Italian Large White pigs divergent for backfat thickness[J].2016,47(3).
[24]Lei Yang,Conghui Li,Fang Liang,etc.MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma cells[J].2017,95.
[25]Zhao,S.,Zhang,J.,Hou,X.,etc.OLFML3 expression is decreased during prenatal muscle development and regulated by microRNA-155 in pigs[J].2012,8(4).
[26]Torres,S.,Bartolomé,R.A.,Mendes,M.,etc.Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer[J].2013,19(21).
[27]Wang, Linlin,Zhang, Fang,Cui, Jian-Ying,etc.CAFs enhance paclitaxel resistance by inducing EMT through the IL-6/JAK2/STAT3 pathway[J].2018,39(5).
[28]Zeng LC,Liu F,Zhang X,etc.hOLF44, a secreted glycoprotein with distinct expression pattern, belongs to an uncharacterized olfactomedin-like subfamily newly identified by phylogenetic analysis.[J].2004,571(1/3).
[29]Kohei Murakami,Shingo Kikugawa,Yasuhiro Kobayashi,etc.Olfactomedin-like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblasts[J].2018,505(2).
[30]Mojesky C,Kyprianou N,Horbinski C.Live free or die: tales of homeless (cells) in cancer.[J].2010,177(3).
[31]M, Caballero,T, Borrás.Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma.[J].2001,282(3).
[32]Nicolas,Neidert,Alexander,von Ehr,Tanja,Z?ller,etc.Microglia-Specific Expression of Olfml3 Is Directly Regulated by Transforming Growth Factor β1-Induced Smad2 Signaling.[J].2018,9.
[33]Bennett, Mariko L.,Bennett, F. Chris,Liddelow, Shane A.,etc.New tools for studying microglia in the mouse and human CNS[J].2016,113(12).
[34]Attaai Abdelraheim,Neidert Nicolas,von Ehr Alexander,etc.Postnatal maturation of microglia is associated with alternative activation and activated TGFβ signaling[J].2018,66(8).
[35]Kroeber M,Paper W,Heersink S,etc.Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression.[J].2008,87(3).
[36]Sasai Y,Onai T,Sasai N,etc.Functional analysis of chick ONT1 reveals distinguishable activities among olfactomedin-related signaling factors[J].2006,123(2).
[37]Sechrist J,LaBonne C,Bronner Fraser-M,etc.Noelin-1 is a secreted glycoprotein involved in generation of the neural crest.[J].2000,2(4).
[38]Plauchu H,Gasc JM,David L,etc.Bone morphogenetic protein-9 is a circulating vascular quiescence factor.[J].2008,102(8).